Peter Noymer serves as Executive Chairman of the Board for PyrAmes and brings more than twenty years of experience developing novel pharmaceutical and medical device products from concept through to market. Previously, Peter was CEO of Kedalion Therapeutics, COO of SteadyMed Therapeutics (acquired by United Therapeutics), and VP of Product R&D for Alexza Pharmaceuticals (acquired […]
Xina Quan is Co-founder and CEO of PyrAmes and has been developing PyrAmes’ technology with Stanford Professor Zhenan Bao since 2015. Prior to starting PyrAmes, Xina led the R&D efforts at Artificial Muscle Inc., a venture-backed start-up spun out of SRI, which resulted in the first commercial application of electroactive polymers. She played a critical […]
Zhenan Bao is a co-founder of PyrAmes and serves as an Advisor and on the Board of Directors. A world-renowned researcher in electronics and wearables, she is currently the K.K. Lee Professor in Chemical Engineering at Stanford University, with courtesy appointments in Chemistry and Material Science and Engineering. She is a member of the National […]
Richard Lim co-founded GSR Ventures in 2004 and made it one of the premier VC funds in the world, investing in early-stage technology companies operating in the US, China, and SE Asia. GSR Ventures focuses on companies that apply AI to drive transformation in Healthcare, Enterprise and Consumer sectors. Richard holds an MBA from Stanford […]
Joe Zhou is one of the most experienced VCs in China, starting in 1999 with Softbank China Venture Capital. He was a Founding Managing Partner at KPCB China and founded Keytone Ventures in 2008. Joe is passionate about identifying market opportunities in technology, mobile internet, healthcare IT and devices. He holds a MSEE from New […]